Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial.

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial. JAMA Oncol. 2020 12 01; 6(12):1939-1946.

View in: PubMed

subject areas

Aged
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Brain Neoplasms
Cytosine Deaminase
Female
Flucytosine
Glioma
Humans
Isocitrate Dehydrogenase
Lomustine
Male
Middle Aged
Recombinant Proteins
Standard of Care
Survival Analysis
Treatment Outcome

authors with profiles

David Maria Cachia